TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T66538	Calcium-activated potassium channel KCa1.1	B25JYA	5-[3-[3-(Trifluoromethyl)phenyl]ureido]-1H-1,2,3-triazole-4-carboxamide	Investigative	10903109	C11H9F3N6O2	314.22	C1=CC(=CC(=C1)NC(=O)NC2=NNN=C2C(=O)N)C(F)(F)F	IC50 = 79432.82 nM	Poor binder
T66538	Calcium-activated potassium channel KCa1.1	B27GAB	5-(5-Methoxybenzotriazol-1-yl)-2H-triazole-4-carboxamide	Investigative	10515414	C10H9N7O2	259.22	COC1=CC2=C(C=C1)N(N=N2)C3=NNN=C3C(=O)N	IC50 = 154881.66 nM	Poor binder
T66538	Calcium-activated potassium channel KCa1.1	B5S9LH	5-(Benzotriazol-1-yl)-2H-triazole-4-carboxamide	Investigative	10331385	C9H7N7O	229.2	C1=CC=C2C(=C1)N=NN2C3=NNN=C3C(=O)N	IC50 = 112201.85 nM	Poor binder
T66538	Calcium-activated potassium channel KCa1.1	BCA7Z8	5-(2-Oxo-5-phenyl-3H-benzimidazol-1-yl)-2H-triazole-4-carboxamide	Investigative	11823359	C16H12N6O2	320.31	C1=CC=C(C=C1)C2=CC3=C(C=C2)N(C(=O)N3)C4=NNN=C4C(=O)N	IC50 = 54954.09 nM	Poor binder
T66538	Calcium-activated potassium channel KCa1.1	BCP42B	5-(2-Nitroanilino)-2H-triazole-4-carboxamide	Investigative	10800545	C9H8N6O3	248.2	C1=CC=C(C(=C1)NC2=NNN=C2C(=O)N)[N+](=O)[O-]	IC50 = 104712.85 nM	Poor binder
T66538	Calcium-activated potassium channel KCa1.1	BEC94B	5-(5-Methyl-2-oxo-3H-benzimidazol-1-yl)-2H-triazole-4-carboxamide	Investigative	10729882	C11H10N6O2	258.24	CC1=CC2=C(C=C1)N(C(=O)N2)C3=NNN=C3C(=O)N	IC50 = 93325.43 nM	Poor binder
T66538	Calcium-activated potassium channel KCa1.1	BL09SA	5-(5-Fluorobenzotriazol-1-yl)-2H-triazole-4-carboxamide	Investigative	10634209	C9H6FN7O	247.19	C1=CC2=C(C=C1F)N=NN2C3=NNN=C3C(=O)N	IC50 = 93325.43 nM	Poor binder
T66538	Calcium-activated potassium channel KCa1.1	BZJ58M	5-(5-Chlorobenzotriazol-1-yl)-2H-triazole-4-carboxamide	Investigative	10849172	C9H6ClN7O	263.64	C1=CC2=C(C=C1Cl)N=NN2C3=NNN=C3C(=O)N	IC50 = 54954.09 nM	Poor binder